Subscribe to RSS - Invacare

Invacare

UPDATED: Invacare offers $130M in senior notes

 - 
02/17/2016

ELYRIA, Ohio – Invacare announced Feb. 17 that it’s offering $130 million aggregate principal amount of 5% convertible senior notes due 2021 in a private offering to qualified institutional buyers.

Invacare readies to submit final report to FDA

 - 
02/12/2016

ELYRIA, Ohio – Invacare could be turning the corner on its “ongoing journey” to lift a consent decree with the Food and Drug Administration that has handicapped the company since late 2012.

Invacare auditor submits third report

 - 
02/11/2016

ELYRIA, Ohio – Invacare’s independent auditor this week issued its certification report for the third phase of the consent decree indicating substantial compliance to the FDA’s quality system regulation.

Reporter's notebook: The year in most read stories

 - 
01/22/2016

YARMOUTH, Maine – All eyes were on the big guns—Drive Medical, Invacare, Inogen and ResMed—in 2015.

Or so it would appear, according to the five most read vendor stories for the year.

The year's most read vendor stories

 - 
Wednesday, January 6, 2016

All eyes were on the big guns—Drive Medical, Invacare, Inogen and ResMed—in 2015.

Or so it would appear, according to the five most read vendor stories for the year.

Name of game in 02: optimize, optimize, optimize

 - 
12/22/2015

With razor-thin margins an ongoing concern in the reimbursement cut-weary oxygen market, respiratory providers need to find the right resources and strategies to maintain profitability.

In brief: Invacare receives feedback from FDA, Liberator ends year with uptick in sales

 - 
12/18/2015

ELYRIA, Ohio – Invacare has received observations from the FDA following an inspection of its corporate headquarters and Taylor Street manufacturing facility.

Invacare receives feedback from FDA

 - 
12/18/2015

ELYRIA, Ohio – Invacare has received observations from the FDA following an inspection of its corporate headquarters and Taylor Street manufacturing facility.

Stock sellers: ResMed, Invacare

 - 
12/17/2015

James Hollingshead, president of the Americas at ResMed, sold 4,500 shares of company stock on Dec. 15 in a transaction valued at $251,775. He sold the shares at an average price of $55.95.

In brief: OIG targets Hoveround, CMS to revise fee schedule

 - 
12/04/2015

WASHINGTON – The Office of Inspector General (OIG) wants Hoveround to pay back the federal government $27 million for power mobility devices that it says do not meet Medicare reimbursement requirements.

Pages